Drug delivery systems based on mesoporous silica nanoparticles for the management of hepatic diseases

Drug delivery systems based on mesoporous silica nanoparticles for the management of hepatic diseases

The liver performs multiple life-sustaining functions. Hepatic diseases, including hepatitis, cirrhosis, and hepatoma, pose significant health and economic burdens globally. Along with the advances in nanotechnology, mesoporous silica nanoparticles (MSNs) exhibiting diversiform size and shape, disti...

Full description

Saved in:
Bibliographic Details
Main Authors: Boyan Liu, Wenshi Liu, Miao Xu, Tongyi Zhao, Bingxin Zhou, Ruilin Zhou, Ze Zhu, Xuchun Chen, Zhiye Bao, Keke Wang, Heran Li
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Mesoporous silica nanoparticles
Drug delivery
Hepatic diseases
Surface modification
MSNs–liver interactions
Hepatocellular carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383524004726
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2211383524004726

Similar Items